19-1218460-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000455.5(STK11):c.334C>T(p.Gln112*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000455.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.334C>T | p.Gln112* | stop_gained | Exon 2 of 10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.334C>T | p.Gln112* | stop_gained | Exon 2 of 9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.1601C>T | non_coding_transcript_exon_variant | Exon 3 of 11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.334C>T | p.Gln112* | stop_gained | Exon 2 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.334C>T | p.Gln112* | stop_gained | Exon 2 of 9 | ENSP00000498804.1 | ||||
STK11 | ENST00000593219.6 | n.*159C>T | non_coding_transcript_exon_variant | Exon 3 of 11 | 3 | ENSP00000466610.1 | ||||
STK11 | ENST00000585748.3 | c.-39C>T | 5_prime_UTR_variant | Exon 4 of 12 | 3 | ENSP00000477641.2 | ||||
STK11 | ENST00000593219.6 | n.*159C>T | 3_prime_UTR_variant | Exon 3 of 11 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Pathogenic:3
The following ACMG criteria was used: PVS1; PM2_SUP; PS4_SUP -
This sequence change creates a premature translational stop signal (p.Gln112*) in the STK11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in STK11 are known to be pathogenic (PMID: 15188174, 16287113). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of Peutz-Jeghers syndrome (PMID: 17404884, 26979979, 30334930). ClinVar contains an entry for this variant (Variation ID: 1075653). For these reasons, this variant has been classified as Pathogenic. -
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Q112* pathogenic mutation (also known as c.334C>T), located in coding exon 2 of the STK11 gene, results from a C to T substitution at nucleotide position 334. This changes the amino acid from a glutamine to a stop codon within coding exon 2. This variant was reported in individual(s) with features consistent with Peutz-Jeghers syndrome; in at least one individual, it was determined to be de novo (Mehenni H et al. Dig Dis Sci, 2007 Aug;52:1924-33; Jelsig AM et al. Int J Colorectal Dis, 2016 May;31:997-1004; Li R et al. Oncol Lett, 2018 Jan;15:717-726; Zhao HM et al. J Pediatr Gastroenterol Nutr, 2019 Feb;68:199-206). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at